Clinical Trial Update: Rifaximin for the Treatment of Irritable Bowel Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rifaximin for irritable bowel syndrome has completed. The update summarizes the trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED